Raymond James Financial Services Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $84.3K | Buy |
|
|||||
|
2024
Q1 | $136K | Sell |
|
|||||
|
2023
Q4 | $103K | Sell |
|
|||||
|
2023
Q3 | $62.6K | Buy |
|
|||||
|
2023
Q2 | $96.6K | Sell |
|
|||||
|
2023
Q1 | $108K | Sell |
|
|||||
|
2022
Q4 | $240K | Sell |
|
|||||
|
2022
Q3 | $649K | Buy |
|
|||||
|
2022
Q2 | $256K | Sell |
|
|||||
|
2022
Q1 | $408K | Buy |
|
|||||
|
2021
Q4 | $513K | Buy |
|
|||||
|
2021
Q3 | $554K | Buy |
|
|||||
|
2021
Q2 | $882K | Sell |
|
|||||
|
2021
Q1 | $977K | Buy |
|
|||||
|
2020
Q4 | $711K | Sell |
|
|||||
|
2020
Q3 | $596K | Buy |
|
|||||
|
2020
Q2 | $876K | Buy |
|